recombinant factor VIII replacement therapy

This page covers all recombinant factor VIII replacement therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Factor VIII.

Targets

Factor VIII

Phase 3 pipeline (1)

• rFVIII (BAY81-8973) on demand · Bayer · Hematology
  rFVIII (BAY81-8973) is a recombinant factor VIII replacement therapy that mimics the natural protein to treat bleeding episodes in patients with hemophilia A.